Molecular & Cellular Toxicology

The Korean Society of Toxicogenomics and Toxicoproteomics (대한독성유전 단백체학회)
권호 표지

Construction and Validation of Human cDNA Microarray for Estimation of Endocrine Disrupting Chemicals (KISTCHIP-400 ver. 1.0)

  • Ryu, Jae-Chun (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science and Technology) ;
  • Kim, Youn-Jung (Cellular and Molecular Toxicology Laboratory, Korea Institute of Science and Technology)
  • Published : 2005.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

Transcript profiling is a particularly valuable tool in the field of steroid receptor biology, as these receptors are ligand-activated transcription factors and therefore exert their initial effects through altering gene expression in responsive cells. Also, an awareness of endocrine disrupting chemicals (EDCs) and their potential screening methods to identify endocrine activity have been increased. Here we developed an in-house cDNA microarray, named KISTCHIP-400 ver. 1.0, with 416 clones, based on public database and research papers. These clones contained estrogen, androgen, thyroid hormone & receptors, sex hormone signal transduction & regulation, c-fos, c-myc, ps2 gene, metabolism related genes etc. Also, to validate the KISTCHIP-400 ver. 1.0, we investigated gene expression profiles with reference hormones, $10^{8}\;M\;17{\beta}-estradiol,\;10^{-7}\;M\;testosterone\;and\;10^{-7}\;M$ progesterone in MCF-7 cell line. As the results, gene expression profiles of three reference hormones were distinguished from each other with significant and identified 33 $17{\beta}-estradiol$ responsive genes. This study is in first step of validation for KISTCHIP-400 ver. 1.0, as following step transcriptional profile analysis on not only low concentrations of EDCs but suspected EDCs using KISTCHIP-400 ver. 1.0 is processing. Our results indicate that the developed microarray may be a useful laboratory tool for screening EDCs and elucidating endocrine disrupting mechanism.

Keywords

References

  1. Fox, G.A. Effects of endocrine disrupting chemicals on wildlife in Canada: past, present, and future. Water Qual. Res. J. Can. 26, 233-251 (2001) https://doi.org/10.4296/cwrj2602233
  2. McMaster, M.E. A review of the evidence for endocrine disruption in Canadian aquatic ecosystems. Water Qual. Res. J. Can. 36, 215-231 (2001)
  3. Francois, E., Wang, D.Y., Fulthorpe, R., Liss, S.N. & Edwards, E. A. DNA microarrays for detecting endocrine- disrupting compounds. Biotechno. Advances 22, 17-26 (2003) https://doi.org/10.1016/j.biotechadv.2003.08.005
  4. Hewitt, M. & Servos, M. An Overview of Substances Present in Canadian Aquatic Environments Associated with Endocrine Disruption. Water Qual. Res. J. Canada. 36, 191-213(2001)
  5. Lister, A.L. & Kraak, GJVD. Endocrine disruption : why is it so complicated? Water Qual. Res. J. Can. 36, 175-190 (2001)
  6. Phillips, B. & Harrison, P. Overview of the endocrine disrupters issue. In: Hester RE, Harrison RM, editors. Issues in environmental science and technology, vol 12: endocrine disrupting chemicals, vol 12. Cambridge (UK): Royal Society of Chemistry; (1-26) (1999)
  7. Jobling, M.A., Bouzekri, N. & Taylor, P.G. Hypervariable digital DNA codes for human paternal lineages: MVR-PCR at the Y-specific minisatellite, MSY1 (DYF155S1). Human Mol. Genet. 7, 643-653(1998) https://doi.org/10.1093/hmg/7.4.643
  8. Huang, C.H. & Sedlak, D.L. Analysis of estrogenic hormones in municipal wastewater effluent and surface water using ELISA and GC/MS/MS. Environ. Toxicol. Chem. 20, 133-139 (2001) https://doi.org/10.1897/1551-5028(2001)020<0133:AOEHIM>2.0.CO;2
  9. Smeds, A. & Saukko, P. Identification and quantification of polychlorinated bisphenols and some endocrine disrupting pesticides in human adipose tissue from Finland. Chemosphere 44, 1463-1471 (2001) https://doi.org/10.1016/S0045-6535(00)00313-1
  10. Sole, R.V., Bonabeau, E., Delgado, J., Fernandez, P. & Marin, J. Pattern formation and optimization in army ant raids. Artificial Life 6, 219-226 (2000) https://doi.org/10.1162/106454600568843
  11. Takeyoshi, M., Yamasaki, K., Sawaki, M., Nakai, M., Noda, S. & Takatsuki, M. The efficacy of endocrine disruptor screening tests in detecting anti-estrogenic effects downstream of receptor-ligand interactions. Toxicol. Lett. 126, 91-98 (2002) https://doi.org/10.1016/S0378-4274(01)00446-5
  12. Nilsen, B.M., Berg, K., Eidem, J.K., Kristiansen, S. I., Brion, F., Porcher, J.M. & Goksoyr, A. Development of quantitative vitellogenin-ELISAs for fish test species used in endocrine disruptor screening. Anal. Bioanal. Chem. 378, 621-633 (2004) https://doi.org/10.1007/s00216-003-2241-2
  13. Imanishi, S., Manabe, N., Nishizawa, H., Morita, M., Sugimoto, M., Iwahori, M. & Miyamoto, H. Effects of oral exposure of bisphenol A on mRNA expression of nuclear receptors in murine placentae assessed by DNA microarray. J. Reprod. Dev. 49, 329-336 (2003) https://doi.org/10.1262/jrd.49.329
  14. Nielsen, M., Hoyer, P.E., Lemmen, J.G., van der Burg, B. & Byskov, A.G. Octylphenol does not mimic diethylstilbestrol-induced oestrogen receptor-alpha expression in the newborn mouse uterine epithelium after prenatal exposure. J. Endocrinol. 167, 29-37 (2000) https://doi.org/10.1677/joe.0.1670029
  15. Inoue, T. Toxicogenomics- a new paradigm of toxicology. In: Toxicogenomics (Inoue, T., Pennie, W. D., eds). Tokyo: Springer, 3-11 (2003)
  16. Terasaka, S. et al. Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ. Health Perspect. 112, 773-781 (2004) https://doi.org/10.1289/ehp.6753
  17. Schena, M., Shalon, D., Davis, R.W. & Brown, P.O. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science 270, 467-470 (1995) https://doi.org/10.1126/science.270.5235.467
  18. Chee, M., Yang. et al. Accessing genetic information with high-density DNA arrays. Science 274, 610-614 (1996) https://doi.org/10.1126/science.274.5287.610
  19. Afshari, C.A., Nuwaysir, E.F. & Barrett, J.C. Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. Cancer Res. 59, 4759-4760 (1999)
  20. Nuwaysir, E.F., Bittner, M., Trent, J., Barrett, J.C. Afshari, C.A. Microarrays and toxicology : the advent of toxicogenomics, Mol. Carcinog. 24, 153-159 (1999) https://doi.org/10.1002/(SICI)1098-2744(199903)24:3<153::AID-MC1>3.0.CO;2-P
  21. Zhang, H., Yu, C.Y. & singer, B. Cell and tumor classification using gene expression data : Construction of forests. Proc. Natl. Acad. Sci. USA 100, 4168- 4172 (2003) https://doi.org/10.1073/pnas.0230559100
  22. Gaido, K.W., Leonard, L.S., Lovell, S., Gould, J.C., Babai, D., Portier, C.J. & McDonnell, D.P. Evaluation of chemicals with endocrine modulating activity in a Yeast-based steroid hormone receptor gene transcription assay. Toxicol. Appl. Pharmacol. 143, 205- 212 (1997). https://doi.org/10.1006/taap.1996.8069
  23. Skakkebaek, N.E. Endocrine disrupters and testicular dysgenesis syndrome. Horm. Res. 57, 43(2002) https://doi.org/10.1159/000058094
  24. Birkett, J.W. & Lester, J.N. Endocrine Disrupters in Wastewater and Sludge Treatment Processes. Boca Raton, FL: CRC Press. (2003)
  25. Abraham, G.E. The Applications of Steroid Radioimmunoassay to Gynecologic Endocrinology. Prog. Gynecol. 1, 111-144 (1975)
  26. Charpentier, A.H., Bednarek, A.K., Daniel, R.L., Hawkins, K.A., Laflin, K.J., Gaddis, S., MacLeod, M.C. & Aldaz, C.M. Effects of estrogen on global gene expression: identification of novel targets of estrogen action. Cancer Res. 60, 5977-5983(2000)
  27. Inoue, A., Yoshida, N., Omoto, Y., Oguchi, S., Yamori, T. & Kiyama, R. Development of cDNA microarray for expression profiling of estrogen responsive genes. J. Mol. Endocrinol. 29, 175-192 (2002) https://doi.org/10.1677/jme.0.0290175
  28. Kumar, P., Mark, P.J., Ward, B.K., Minchin, R.F. & Ratajczak, T. Estradiol-regulated expression of the immunophilins cyclophilin 40 and FKBP52 in MCF- 7 breast cancer cells. Biochem. Biophys. Res. Commun. 284, 219-225 (2001)
  29. Li, S.S. & Hou, E.W. Estrogen-induced expression of mouse lactate dehydrogenase-A gene. Cell Biol. Int. Rep. 13, 619-624 (1989) https://doi.org/10.1016/0309-1651(89)90112-4
  30. Soulez, M. & Parker, M.G. Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J. Mol. Endocrinol. 27, 259-274 (2001) https://doi.org/10.1677/jme.0.0270259
  31. Sawai, T., Bernier, F., Fukushima, T., Hashimoto, T., Ogura, H. & Nishizawa, Y. Estrogen induces a rapid increase of calcium-calmodulin-dependent protein kinase II activity in the hippocampus. Brain Res. 950, 308-311 (2002) https://doi.org/10.1016/S0006-8993(02)03186-4
  32. Chen, I., Hsieh, T., Thomas, T. & Safe, S. Identification of estrogen-induced genes downregulated by AhR agonists in MCF-7 breast cancer cells using suppression subtractive hybridization. Gene 262, 207- 214 (2001) https://doi.org/10.1016/S0378-1119(00)00530-8
  33. Byrne, J.A., Mattei, M.G., Basset, P. & Gunning, P. Identification and in situ hybridization mapping of a mouse Tpd5211 (D53) orthologue to chromosome 10A4-B2. Cytogenet. Cell Genet. 81, 199-201 (1998). https://doi.org/10.1159/000015029
  34. Abbott, D.W., Laszczak, M., Lewis, J.D., Su, H., Moore, S.C., Hills, M., Dimitrov, S. & Ausio, J. Structural characterization of macroH2A containing chromatin. Biochemistry 43, 1352-1359 (2004)
  35. Leung, L.K. & Wang, T.T. Paradoxical regulation of Bcl-2 family proteins by 17beta-oestradiol in human breast cancer cells MCF-7. Br. J. Cancer. 81, 387-392 (1999). https://doi.org/10.1038/sj.bjc.6690706
  36. Tusher, V., Tribshirani, R. & Chu, C. Significance analysis of microarrays applied to ionizing radiation response. Proc. Natl. Acad. Sci. USA 98, 5116-5121 (2001) https://doi.org/10.1073/pnas.091062498